Loading organizations...
Arcaea is a Boston, Massachusetts-based biotechnology company that develops sustainable, bioengineered ingredients and products for the global beauty and personal care industry. The venture-backed startup leverages advanced DNA sequencing and biological engineering to create novel cosmetic formulations, operating globally through both business-to-business ingredient development and direct-to-consumer retail sales channels. To scale its proprietary technology platform across the skincare and haircare markets, the company secured $78 million in Series A funding from a syndicate of strategic investors that includes Chanel, Givaudan, and Wittington Ventures. Operating as an independent spinout from parent incubator Ginkgo Bioworks, the enterprise recently expanded its commercial footprint by launching Future Society, a consumer fragrance brand featuring unique scents engineered from the sequenced DNA of extinct flowers. Arcaea was officially founded in 2021 by entrepreneur and former Living Proof executive Jasmina Aganovic.
Arcaea has raised $78.0M across 1 funding round.
Arcaea has raised $78.0M in total across 1 funding round.
Arcaea has raised $78.0M in total across 1 funding round.
Arcaea's investors include Cascade Investment, Chanel, Givaudan, Viking Global Investors, Wittington Ventures.
Arcaea has raised $78.0M across 1 funding round. Most recently, it raised $78.0M Series A in October 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 27, 2021 | $78M Series A | — | Cascade Investment, CHANEL, Givaudan, Viking Global Investors, Wittington Ventures | Announced |
